IBEX Technologies (IBT) Stock Price, News & Analysis

Company Overview

IBEX Technologies Inc., through its subsidiaries, manufactures and markets enzymes for biomedical use in Canada, the United States, Germany, the United Kingdom, and internationally. It offers a portfolio of recombinant glycosaminoglycan lyases, including Heparinase I, Heparinase II, Heparinase III, Chondroitinase AC, and Chondroitinase B; collagen ELISAs for the study of synthesis and degradation of connective tissue components; collagen antibodies; and diamine oxidase liquid. The company also manufactures and markets a range of arthritis assays, which are used in osteoarthritis research. In addition, it provides lyophilization services for making disposable medical device components; and custom fermentation and contract manufacturing services. It serves manufacturers of medical devices, quality control labs, low molecular weight heparin manufacturers, and academic research institutions. IBEX Technologies Inc. was incorporated in 1972 and is based in Montreal, Canada.

Key Stats

• Today's Range: C$1.44 to C$1.44
• 50-Day Range: C$1.44 to C$1.44
• 52-Week Range: C$0.75 to C$1.45
• Volume: 200 shs
• Average Volume: 68,888 shs
• Market Capitalization: C$35.54 million
• P/E Ratio: 11.52
• Dividend Yield: 3.11%
• Price Target: N/A
• Consensus Rating: N/A

IBT Stock Analysis - Frequently Asked Questions

How have IBT shares performed this year?

IBEX Technologies' stock was trading at C$1.44 on January 1st, 2025. Since then, IBT shares have increased by 0.0% and is now trading at C$1.44.
View the best growth stocks for 2025 here.

How do I buy shares of IBEX Technologies?

Shares of IBT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What other stocks do shareholders of IBEX Technologies own?

Based on aggregate information from My MarketBeat watchlists, some other companies that IBEX Technologies investors own include Aurora Cannabis (ACB), Acerus Pharmaceuticals (TRLPF), Air Canada (AC), American Airlines Group (AAL), Cognex (CGNX), Baytex Energy (BTE) and Bank of Montreal (BMO).

Industry, Sector and Symbol

• Stock Exchange: CVE
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: N/A
• Current Symbol: CVE:IBT
• CUSIP: N/A
• CIK: N/A
• Web: www.ibex.ca
• Phone: +1-514-3444004
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): C$0.12
• Trailing P/E Ratio: 11.52
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: C$3.10 million
• Net Margins: 53.78%
• Pretax Margin: N/A
• Return on Equity: 21.95%
• Return on Assets: 6.42%

Debt

• Debt-to-Equity Ratio: 11.06
• Current Ratio: 6.24
• Quick Ratio: 4.93

Sales & Book Value

• Annual Sales: C$5.77 million
• Price / Sales: 6.15
• Cash Flow: C$0.92 per share
• Price / Cash Flow: 1.56
• Book Value: C$0.58 per share
• Price / Book: 2.48

Miscellaneous

• Outstanding Shares: 24,677,792
• Free Float: N/A
• Market Cap: C$35.54 million
• Optionable: Not Optionable
• Beta: -0.05